{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:24:31Z","timestamp":1786944271121,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Advances in cancer diagnostics raise questions about when and how to de-implement traditional approaches; however, these processes remain poorly described. At St. Jude Children\u2019s Research Hospital (SJCRH), routine conventional cytogenetics for pediatric acute lymphoblastic leukemia (ALL) diagnosis was de-implemented in 2018 following adoption of clinical genomics. This study aimed to map this process to inform future diagnostic de-implementation initiatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Interviews were conducted with SJCRH staff involved or impacted by cytogenetics de-implementation. Data were analyzed using thematic and rapid qualitative analysis informed by the Consolidated Framework for Implementation Research. Member-checking was used to verify and refine process maps, which were subsequently reviewed by an external expert panel, representing diverse settings, through focus group discussions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen SJCRH clinicians participated. De-implementation was described as successful, with no negative impact on patient outcomes. Decision-making began with internal correlation studies that demonstrated superior diagnostic performance of clinical genomics. De-implementation was viewed as a natural evolution that improved molecular classification, resource allocation, and workflow efficiency. Perceived risks included loss of cytogenetics competency, delayed turnaround time, and career insecurity, all addressed institutionally. Lessons learned highlighted the importance of deliberate discussion about logic and evidence supporting de-implementation. Fifteen external experts offered suggestions to improve process map generalizability, highlighting institutional- and system-level considerations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>De-implementation of cytogenetics in ALL in favor of clinical genomics was successful at SJCRH. This study offers an example of diagnostic de-implementation in cancer care and proposes a structured approach to guide future efforts. De-implementation should be considered alongside introduction of novel diagnostic approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1885970","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:33:12Z","timestamp":1786941192000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mapping the de-implementation of traditional diagnostic tests in pediatric acute lymphoblastic leukemia"],"prefix":"10.3389","volume":"16","author":[{"given":"Marta","family":"Salek","sequence":"first","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]},{"name":"Department of Global Pediatric Medicine, St Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Busby","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine","place":["Atlanta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Webb","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan E.","family":"Graetz","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]},{"name":"Department of Global Pediatric Medicine, St Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[{"name":"Department of Pathology, St Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickhill","family":"Bhakta","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]},{"name":"Department of Global Pediatric Medicine, St Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan C.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Eshelman School of Pharmacy, University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, St Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/s0140-6736(21)00673-5","article-title":"The Lancet Commission on diagnostics: transforming access to diagnostics","volume":"398","author":"Fleming","year":"2021","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-20-1631","article-title":"Genomes for Kids: The scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing","volume":"11","author":"Newman","year":"2021","journal-title":"Cancer Discov"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2017.00258","article-title":"Integration of next-generation sequencing to treat acute lymphoblastic leukemia with targetable lesions: The St. Jude Children's Research Hospital approach","volume":"5","author":"Inaba","year":"2017","journal-title":"Front Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1038\/s41467-018-06485-7","article-title":"Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome","volume":"9","author":"Rusch","year":"2018","journal-title":"Nat Commun"},{"key":"B5","article-title":"Pediatric acute lymphoblastic leukemia, Version 1.2026","year":"2026"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2024534","article-title":"Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers","volume":"384","author":"Duncavage","year":"2021","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/po-24-00788","article-title":"Challenging conventional diagnostic methods by comprehensive molecular diagnostics: a nationwide prospective comparison in children with ALL","volume":"9","author":"Boer","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/jco.18.00589","article-title":"Conceptualizing de-implementation in cancer care delivery","volume":"37","author":"Norton","year":"2018","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s43058-020-00035-3","article-title":"Defining and conceptualizing outcomes for de-implementation: key distinctions from implementation outcomes","volume":"1","author":"Prusaczyk","year":"2020","journal-title":"Implement Sci Commun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21203\/rs.3.rs-662637\/v1","article-title":"De-implementing low-value care in cancer care delivery: a systematic review","volume":"17","author":"Alishahi Tabriz","year":"2022","journal-title":"Implement Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/jhm.13257","article-title":"Methodological progress note: De-implementation of low-value care","volume":"19","author":"Kripalani","year":"2024","journal-title":"J Hosp Med"},{"key":"B13","article-title":"Using process mapping to improve nursing practice and patient care","volume":"19","author":"McEvoy","year":"2004","journal-title":"Prof Nurse"},{"key":"B14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12913-021-06254-1","article-title":"Process mapping in healthcare: a systematic review","volume":"21","author":"Antonacci","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","article-title":"The updated Consolidated Framework for Implementation Research based on user feedback","volume":"17","author":"Damschroder","year":"2022","journal-title":"Implement Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13012-021-01181-5","article-title":"Conceptualizing outcomes for use with the Consolidated Framework for Implementation Research (CFIR): the CFIR Outcomes Addendum","volume":"17","author":"Damschroder","year":"2022","journal-title":"Implement Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10488-010-0327-7","article-title":"Advancing a conceptual model of evidence-based practice implementation in public service sectors","volume":"38","author":"Aarons","year":"2011","journal-title":"Adm Policy Ment Health"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4324\/9781003109945-14","article-title":"Systematic review of the Exploration, Preparation, Implementation, Sustainment (EPIS) framework","volume":"14","author":"Moullin","year":"2019","journal-title":"Implement Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13012-020-0977-0","article-title":"Evaluating and optimizing the consolidated framework for implementation research (CFIR) for use in low- and middle-income countries: a systematic review","volume":"15","author":"Means","year":"2020","journal-title":"Implement Sci"},{"key":"B20","volume-title":"Chapter 6. Theory of Reasoned Action, Theory of Planned Behavior, and the Integrated Behavioral Model","author":"Montano","year":"2015"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/1049732316654870","article-title":"Member checking: A tool to enhance trustworthiness or merely a nod to validation","volume":"26","author":"Birt","year":"2016","journal-title":"Qual Health Res"},{"key":"B22","unstructured":""},{"key":"B23","unstructured":"World Bank country and lending groups"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10488-013-0528-y","article-title":"Purposeful sampling for qualitative data collection and analysis in mixed method implementation research","volume":"42","author":"Palinkas","year":"2015","journal-title":"Adm Policy Ment Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/104973239500500201","article-title":"The significance of saturation","volume":"5","author":"Morse","year":"1995","journal-title":"Qual Health Res"},{"key":"B26","unstructured":"Qualitative methods in rapid turn-around health services research\n          \n          \n            \n              Hamilton\n              AB\n            \n          \n          \n          2013"},{"key":"B27","volume-title":"Mural (Version 2026)","year":"2026"},{"key":"B28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/1744987107081254","article-title":"Memoing in qualitative research","volume":"13","author":"Birks","year":"2008","journal-title":"J Res Nurs"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.3324\/haematol.2024.286626","article-title":"B cell lymphoblastic leukemia\/lymphoma with mutated IKZF1 N159Y: clinical and genetic features of an emerging entity","volume":"110","author":"Alvey","year":"2025","journal-title":"Haematologica"},{"key":"B30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1615\/critreveukaryotgeneexpr.2016015724","article-title":"Clinical genomics: challenges and opportunities","volume":"26","author":"Vijay","year":"2016","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35065","article-title":"The role of relative advantage for development of sequencing-based diagnostics for pediatric cancer in low- and middle-income countries","volume":"130","author":"Berger","year":"2024","journal-title":"Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13012-021-01089-0","article-title":"Changing behaviour, 'more or less': do implementation and de-implementation interventions include different behaviour change techniques","volume":"16","author":"Patey","year":"2021","journal-title":"Implement Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.22541\/au.175673365.53679045\/v1","article-title":"Facilitators and barriers for implementing diagnostic sequencing technology for pediatric oncology in low- and middle-income countries","volume":"73","author":"Busby","year":"2026","journal-title":"Pediatr Blood Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.13154","article-title":"Sustainment of continuous pulse oximetry deimplementation: Analysis of Eliminating Monitor Overuse study data from six hospitals","volume":"18","author":"Faerber","year":"2023","journal-title":"J Hosp Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13012-022-01238-z","article-title":"Randomized controlled trials in de-implementation research: a systematic scoping review","volume":"17","author":"Raudasoja","year":"2022","journal-title":"Implement Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.13978","article-title":"Waste in the US health care system: estimated costs and potential for savings","volume":"322","author":"Shrank","year":"2019","journal-title":"JAMA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2025.3050","article-title":"Projected savings from reducing low-value services in Medicare","volume":"6","author":"Kim","year":"2025","journal-title":"JAMA Health Forum"},{"key":"B38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0140-6736(16)32586-7","article-title":"Levers for addressing medical underuse and overuse: achieving high-value health care","volume":"390","author":"Elshaug","year":"2017","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71269","article-title":"Reducing home labs for pediatric patients with solid tumors: impact of a novel clinical practice guideline on safety, cost, and quality of life","volume":"14","author":"Wall","year":"2025","journal-title":"Cancer Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29579","article-title":"Implementation science in pediatric oncology: a narrative review and future directions","volume":"69","author":"Phillips","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1200\/op.22.00130","article-title":"Implementation and impact of Choosing Wisely recommendations in oncology","volume":"18","author":"Nagarajah","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003635","article-title":"The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question","volume":"6","author":"O'Brien","year":"2022","journal-title":"Blood Adv"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(23)00019-0","article-title":"Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study","volume":"24","author":"Mauz-Korholz","year":"2023","journal-title":"Lancet Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s1470-2045(12)70600-9","article-title":"Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial","volume":"14","author":"Vora","year":"2013","journal-title":"Lancet Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.64.6364","article-title":"Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: Study ALL10 from the Dutch Childhood Oncology Group","volume":"34","author":"Pieters","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1885970\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:33:22Z","timestamp":1786941202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1885970\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":45,"alternative-id":["10.3389\/fonc.2026.1885970"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1885970","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"article-number":"1885970"}}